Husky Injection Molding Systems announced at the end of last week it has entered into a definitive agreement to acquire Schöttli Group of Diessenhofen, Switzerland, recognized as a global leader in medical and closure mold making. The sale is expected to close in early December.
Schöttli is a global leader in a number of select medical applications, such as syringes, infusion/transfusion products, diagnostic systems and feminine care items. Husky hot runner customers will benefit from product improvements based on strengthened knowledge, and existing Schöttli customers will have more streamlined access to Husky's hot runner, controller and injection molding machine products, say the company. In addition, Schöttli's closures business complements Husky's existing closures business by providing additional technology and capacity in both established and growing markets.
"Husky has enjoyed a strong and long-lasting relationship with Schöttli and we have long shared a mutual commitment to quality, technology innovation and customer satisfaction, said John Galt, Husky's President and CEO. "Through this acquisition, we will be able to work with the many skilled people at Schöttli as one team to deliver more value to customers, particularly in the medical and closures markets. Our goal is to expand our knowledge, expertise, capacity and global footprint so that we can provide the best possible support to customers in these areas of our business."
By bringing Husky and Schöttli together, customers will benefit from an enhanced level of technical expertise to produce the highest quality parts, the additional capacity to increase speed to market, and improved responsiveness delivered by the industry's largest global service and support network, say the company further. Following the close of this transaction, Schöttli's headquarters in Diessenhofen, Switzerland, as well as other facilities in San Dimas, California, and Suzhou, China, will become part of Husky's global network of locations.
"As a technical leader with a growing customer base, we are proud of what our team has accomplished and have confidence this relationship will positively benefit customers, said Thomas Anderegg, President and CEO of Schöttli. "By joining with Husky we are partnering with a like-minded industry leader to continue providing leading-edge technology, with the advantage of Husky's extensive sales and service network to better support our global customer base. We are excited about this new chapter in our company's history and look forward to the benefits and synergies this acquisition will bring."
Schöttli is a globally positioned specialist in the development and manufacture of high-precision and high-performance molds and complete solutions for the volume production of plastic injection mold parts for medical applications and closures. With its manufacturing and service plants in America (San Dimas, USA), Asia (Suzhou, China) and Europe (Diessenhofen, Switzerland) it is present in all important markets.
Husky Injection Molding Systems Ltd. is a leading global supplier of injection molding equipment and services to the plastics industry. The company has more than 40 service and sales offices, supporting customers in over 100 countries. Husky's manufacturing facilities are located in Canada, the United States, Luxembourg, Austria and China.
About CGS Management
CGS Management is a Swiss based Private Equity advisor with an industrial track record. The advised funds are investing in small and mid sized industrial companies with a focus on technological innovation, organic growth and buy & build. Based on the industrial experience of ist partners, CGS invests in industries such as electronics and electrical engineering, machinery and equipment, measurement and control systems & sensors, construction supplies, plastics industry, and industrial equipment.
www.schoettli.com, www.husky.ca, www.cgs-management.comWeitere News im plasticker